Table 2.
Registry | Year Registry was established | Current data | Person-years | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Total countries* | Total Registry sites** | Total patients | Total person-years from birth to last follow-up† | Total person-years from diagnosis to last follow-up‡ | Total person-years from treatment initiation to last follow-up§ | |||||
Person-years | N | Person-years | N | Person-years | N | |||||
ICGG Gaucher Registry | 1991 | 64 | 278 | 6872 | 266,543 | 6844 | 112,115 | 6481 | 67,470 | 5595 |
Fabry Registry | 2001 | 47 | 243 | 7930 | 344,445 | 7897 | 78,220 | 7267 | 38,523 | 5017 |
MPS I Registry | 2003 | 41 | 144 | 1325 | 18,598 | 1323 | 13,497 | 1297 | 10,086 | 1176 |
Pompe Registry | 2004 | 47 | 240 | 2467 | 87,251 | 2463 | 21,761 | 2405 | 13,510 | 2210 |
Total | 805 | 18,594 | 716,837 | 18,527 | 235,593 | 17,450 | 129,589 | 13,798 |
All Data as of February 2022
*Includes currently and historically active countries/regions
**Includes currently active sites where at least one patient is enrolled
†Data are shown for patients with non-missing dates of birth and last follow-up
‡Data are shown for patients with non-missing dates of diagnosis and last follow-up
§Data are shown for ever-treated patients with non-missing dates of treatment initiation and last follow-up
MPS I, Mucopolysaccharidosis type I